December 14, 2021 -- Roche announced the launch of the Avenio Edge System, a core component of Roche's strategy to advance sequencing technologies. The system is built on Roche's foundational capabilities to deliver a fully automated, integrated sequencing solution.
Avenio Edge is a preanalytical platform for sequencing library preparation, target enrichment, and quantification steps that deliver integrated, end-to-end control with reliable, consistent, high-quality results, according to the firm.
Next-generation sequencing samples are delicate, and every step of sample preparation has the potential to impact results. The Avenio Edge System's high reproducibility and low error rate can support a laboratory's goal of reducing the number of rejected samples that otherwise might have to be recollected.
The system features ready-to-use components in addition to customizable workflow parameters, making it a scalable, cost-efficient solution for sequencing laboratories seeking high performance and agility. This Avenio Edge System has demonstrated a more than a 96% lower error opportunity and an 84% reduction in hands-on time. In addition, Avenio Edge has a setup to initiation time of 20 minutes.
The Avenio Edge System will be available at select locations worldwide with timelines that vary by country.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
